Parijat Bhatnagar, program director for cell-based medicine at SRI International in Menlo Park, has received an innovator's award from the National Institute of Biomedical Imaging and Bioengineering, part of the National Institues of Health.
The award comes with $3 million in research funding over five years.
His research is focused on using immune cell engineering against the dengue virus. The goal is to engineer cells that travel to diseased areas in the body, figure out how bad the disease is, and synthesize proportionate amounts of therapeutics to neutralize the disease.
The award is part of the National Insitutes of Health's "High-Risk, High-Reward Research Program."